• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    1.87 Down 0.06(3.11%) Jul 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.93
    Open:1.90
    Bid:1.87 x 5000
    Ask:1.89 x 5000
    1y Target Est:5.50
    Beta:1.64
    Next Earnings Date: 6-Aug-15CTIC Earnings announcement
    Day's Range:1.85 - 1.90
    52wk Range:1.65 - 2.94
    Volume:681,341
    Avg Vol (3m):3,220,000
    Market Cap:337.04M
    P/E (ttm):N/A
    EPS (ttm):-0.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICDown 3.11%337.04M
    BMYUp 0.36%108.20B
    RHHBYUp 0.05%245.78B
    SNYDown 2.17%137.65B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.38
    Quarterly EPS Est (Jun-15) :-0.10
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback